Literature DB >> 29408295

KIR2DS1, 2DS5, 3DS1 and KIR2DL5 are associated with the risk of head and neck squamous cell carcinoma in Iranians.

Shaghik Barani1, Bijan Khademi2, Elham Ashouri3, Abbas Ghaderi4.   

Abstract

BACKGROUND: Activating and inhibitory KIR receptors (aKIR, iKIR) control the development and function of NK cells whose function alterations adjust the tumor microenvironment immunity. This research was conducted to determine the KIRs gene impact on genetic predisposition to Head and Neck Squamous Cell Carcinoma (HNSCC) in Iranians.
METHODS: KIR genotyping using sequence-specific primers-polymerase chain reaction (SSP-PCR) method was performed to identify the presence of all 16 KIR genes in 285 HNSCC patients, including laryngeal, oral cavity and pharyngeal SCC and 273 controls (CNs).
RESULTS: Comparison of KIRs gene frequency between HNSCC and CNs revealed a highly significant increase in KIR2DL5, 2DS1, 2DS5, 3DS1 and CxT4 genotype and a decrease in KIR2DS4 deleted variant and AA genotype carriers. A significant increase was noted in individuals withhigher iKIRs than aKIRs in HNSCC compared with CNs. Individuals with ≥4 iKIR and those with ≥5 aKIRs were significantly more common in HNSCC than CNs. 68distinct KIR genotypes were identified in 558 individuals.
CONCLUSION: Our findings determined the detrimental impact of KIR2DS1, 2DS5, 3DS1, 2DL5 and CxT4 genotype as well as the protective impact of KIR2DS4del and AA genotype on genetic predisposition to HNSCC in Iranians.
Copyright © 2018 American Society for Histocompatibility and Immunogenetics. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Head and neck squamous cell carcinoma (HNSCC); Killer immunoglobulin like receptors (KIRs); NK cells; SSP-PCR

Mesh:

Substances:

Year:  2018        PMID: 29408295     DOI: 10.1016/j.humimm.2018.01.012

Source DB:  PubMed          Journal:  Hum Immunol        ISSN: 0198-8859            Impact factor:   2.850


  6 in total

1.  KIRs gene content diversity in Iranians with urothelial bladder cancer.

Authors:  Elham Jamali; Shaghik Barani; Fahimeh Yousefinejad; Ali Ariafar; Ghoalm Reza Talei; Abbas Ghaderi
Journal:  Mol Biol Rep       Date:  2018-07-02       Impact factor: 2.316

2.  Combination of KIR2DS4 and FcγRIIa polymorphisms predicts the response to cetuximab in KRAS mutant metastatic colorectal cancer.

Authors:  A Borrero-Palacios; A Cebrián; M T Gómez Del Pulgar; R García-Carbonero; P Garcia-Alfonso; E Aranda; E Elez; R López-López; A Cervantes; M Valladares; C Nadal; J M Viéitez; C Guillén-Ponce; J Rodríguez; I Hernández; J L García; R Vega-Bravo; A Puime-Otin; J Martínez-Useros; L Del Puerto-Nevado; R Rincón; M Rodríguez-Remírez; F Rojo; J García-Foncillas
Journal:  Sci Rep       Date:  2019-02-22       Impact factor: 4.379

3.  qKAT: Quantitative Semi-automated Typing of Killer-cell Immunoglobulin-like Receptor Genes.

Authors:  Jyothi Jayaraman; Vitalina Kirgizova; Da Di; Christopher Johnson; Wei Jiang; James A Traherne
Journal:  J Vis Exp       Date:  2019-03-06       Impact factor: 1.355

4.  Coexistence of inhibitory and activating killer-cell immunoglobulin-like receptors to the same cognate HLA-C2 and Bw4 ligands confer breast cancer risk.

Authors:  Elham Ashouri; Karan Rajalingam; Shaghik Barani; Shirin Farjadian; Abbas Ghaderi; Raja Rajalingam
Journal:  Sci Rep       Date:  2021-04-12       Impact factor: 4.379

5.  KIR-HLA gene diversities and susceptibility to lung cancer.

Authors:  Marjan Hematian Larki; Elham Ashouri; Shaghik Barani; Seiyed Mohammad Ali Ghayumi; Abbas Ghaderi; Raja Rajalingam
Journal:  Sci Rep       Date:  2022-10-14       Impact factor: 4.996

Review 6.  Overview of Strategies to Improve Therapy against Tumors Using Natural Killer Cell.

Authors:  Chaopin Yang; Yue Li; Yaozhang Yang; Zhiyi Chen
Journal:  J Immunol Res       Date:  2020-01-21       Impact factor: 4.818

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.